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Abstract 
The effect of phorbol 12-myristate 13-acetate (PMA) on the expression and shedding of intercellular adhesion molecule-1 (ICAM-1) 
was investigated on the hematopoietic cell lines K 562 and U 937 using flow cytometry, fluorescence microscopy and ELISA technique. 
At low concentration of 1 nM, PMA stimulated the expression of ICAM-1 on the cell surface about 4-fold within 24 h, whereas a 
short-term treatment with 100 nM PMA led to the shedding of 35% of ICAM-1 from the surface of K 562 cells. The release of surface 
ICAM-1 was found on single cells by fluorescence microscopy to be a uniform process proceeding within 15 min. The shedding of 
ICAM-1 correlated with elevated levels of slCAM-1 in the supernatants of cultured cells. Also on K 562 cells stimulated by TNF-a, a 
PMA-induced release of ICAM-I was observed in addition to the known spontaneous shedding. In contrast to the results with K 562 
cells, no PMA-induced shedding of ICAM-I was found on U 937 cells. This indicates a cell-specific process for K 562 cells. The 
PMA-mediated release of ICAM-1 from K 562 cells suggests that the shedding process does not only occur in parallel to the surface 
expression of ICAM-1, but may be controlled by particular mechanisms of down-regulation. 
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1. Introduction 
Intercellular adhesion molecule-1 (ICAM-1, CD54) is a 
member of the Ig supergene family and plays an important 
role in mediating immune and inflammatory response [1-  
3]. It is involved in cell-cell contacts by binding to the 
leukocyte integrin adhesion receptors LFA 1 
(CDl la /CD18)  and MAC-1 (CDl lb /CD18)  [3,4]. 
ICAM-1 is expressed on the surface of hematopoietic and 
non-hematopoietic cells and strongly induced by proin- 
flammatory cytokines uch as TNF-a,  IL-1 [3 and IFN-~/as 
well as by phorbol esters [5-8]. 
A soluble form of ICAM-I (sICAM-1) has been re- 
Abbreviations: ICAM-1, intercellular adhesion molecule-l; slCAM-1, 
soluble intercellular adhesion molecule-l; PMA, phorbol 12-myristate 
13-acetate; TNF-c~, tumor necrosis factor-a; IFN-% interferon-~/; FCS, 
fetal calf serum; PBS, phosphate: buffered saline; MFI, mean fluorescence 
intensity; DTAF, dichlorotriazinyl aminofluorescein. 
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ported to be present in normal human serum [9]. Increased 
levels of sICAM-1 were observed in the serum at inflam- 
matory, neoplastic and immune diseases [10,11] and were 
also found in the supernatants of cultured cells after induc- 
tion by cytokines [12,13]. The proteolytic release (shed- 
ding) of the extracellular domains of adhesion molecules 
and receptors is discussed as one mechanism of down-reg- 
ulation of surface proteins during inflammation [14,15]. 
But the mechanisms of this process are not yet well 
understood. The shedding of ICAM-1 was observed in 
parallel to the cytokine-induced expression on cultured 
melanoma cells [13,16,17]. It is still unclear whether both 
processes, expression and shedding, are regulated together 
or  not.  
The physiological function of slCAM is still under 
investigation. Several studies have demonstrated that 
sICAM-I is able to limit the interaction of transmembrane 
ICAM-1 with the integrins LFA-1 and MAC-1 [18], al- 
though slCAM-1 isolated from different cell types can 
differ in its inhibitory activity [19]. 
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In this study we investigated the expression of ICAM-1 
on and its release from the surface of the hematopoietic 
cell lines K 562 and U 937. On K 562 cells we found that 
phorbol ester (PMA) stimulated the shedding of ICAM-I 
independently of an additional activation of the cells by 
tumor necrosis factor-a (TNF-a). Since PMA-induced 
shedding was not found on the myelomonocytic cells U 
937, this process eems to be a specific phenomenon. 
with buffer, resuspended and incubated with DTAF- 
labelled polyclonal goat-anti-mouse antibody for 30 min at 
4°C. Then the cells were washed twice and resuspended in 
buffer. Labelled cells were analysed on a flow cytometer 
(EPICS PROFILE II, Coulter Electronics). Nonspecific or 
Fc-receptor-mediated labelling could be excluded by test- 
ing the binding of irrelevant monoclonal antibodies. 
2.4. Determination of slCAM-1 
2. Materials and methods 
2.1. Cells, reagents and antibodies 
The human myelomonocytic cell line U 937 was ob- 
tained from the American Type Culture Collection (ATCC, 
Rockville, MD, USA) and the human erythroleukemic cell 
line K 562 from the German Collection of Microorganisms 
and Cell Cultures (Braunschweig, Germany). All culture 
media, fetal calf serum, L-glutamine and gentamycin were 
obtained from Gibco BRL (Grand Island, NY, USA). 
TNF-c~ was purchased from R and D Systems Europe 
(Abingdon, Oxon, UK). Phorbol 12-myristate 13-acetate 
(PMA) and all other reagents were from Sigma Chemie 
(Deisenhofen, Germany). For immunochemical detection 
of ICAM-1, the monoclonal anti-ICAM-1 antibody (anti- 
CD54, clone 84H10) and the polyclonal DTAF- or peroxi- 
dase-labelled goat-anti-mouse IgG antibodies (F(ab') 2 
fragment) from Dianova (Hamburg, Germany) were used. 
2.2. Cell culture 
Cells of both cell lines were cultured in Iscove's Dul- 
becco Medium supplemented with 10% (v/v)  fetal calf 
serum, 2 mM L-glutamine and 20 Ixg/ml gentamycin i  
25 cm 2 tissue culture flasks at 37°C in a humidified 
atmosphere with 6.5% CO 2. Culture initiated at a density 
of 2 • 105 cells/ml grew to about 10 6 cells/ml within two 
days. 24 h before the experiment, the cells (2-105 
cells/ml) were seeded in fresh culture medium in a 24-well 
plate and incubated with 1 nM PMA or 60 U/ml  TNF-e~. 
Control cells were cultured without hese additions for the 
same time. For immunofluorescence studies, the cells were 
harvested, separated from the supernatants by centrifuga- 
tion (1600 X g) and washed once in PBS. Cell viability 
was more than 95% as assessed by trypan blue exclusion. 
2.3. lmmunofluorescence staining of cells 
The supernatants of cultured cells were separated by 
centrifugation and stored at -20°C until use. Soluble 
ICAM-1 (slCAM-1) was determined with a commercially 
available sandwich ELISA (T Cell Diagnostics, Cam- 
bridge, UK), the detection limit was 0.1 ng/ml. 
2.5. Fluorescence microscopy 
2.105 cells were marked with mAb ICAM-1 (clone 
84H10) and DTAF-labelled polyclonal goat-anti-mouse 
IgG antibody. The labelled cells were filled in a perfusion 
chamber with a polylysine coated cover slip on the bottom 
and placed on the stage of an Olympus IMT-2 inverted 
fluorescence microscope. After 30 min at room tempera- 
ture for attachment of the cells, they were perfused at 37°C 
with PBS-medium for 10 min and with additional 100 nM 
PMA for further 20 min. Images were obtained at 490 nm 
excitation and 525 nm emission wavelength by a Hama- 
matsu C2400-87 intensified CCD camera and analysed 
using the Olympus CUE/RMS software package. 
2.6. Western analyses 
Cells and cell culture supernatants were separated by 
centrifugation at 1600 ×g.  Supernatants were passed 
through microcentrifuge filters (Ultrafree, 10000 NMWL, 
Sigma) at 46000 X g for 20 min. Bound proteins were 
washed and eluted with PBS. The cells were rinsed twice 
with PBS and sonicated in lysis buffer (1% n-octyl-gluco- 
pyranoside, 5 mM EDTA, pepstatin (100 Ixg/ml), antipain 
(100 Ixg/ml), benzamidin (1.8 mg/ml), and phenyl- 
methylsulfonylfluoride (4 mg/ml). Proteins were sepa- 
rated on SDS-polyacrylamide g ls (11% total acryl amide), 
transferred tonitrocellulose (Schleicher and Schiill, Dassel, 
Germany), and probed by monoclonal antibody 84H10. 
Proteins binding the anti-CD54 antibody were detected by 
peroxidase-labelled polyclonal goat anti-mouse antibodies. 
Indirect immunofluorescence staining of the cells was 
performed with the monoclonal anti-ICAM-1 antibody 
(clone 84H10) and DTAF-labelled polyclonal goat-anti- 
mouse IgG antibody. Surface ICAM-1 was labelled by 
incubation with 0.5 ixg mAb ICAM-1/105 cells in FACS 
buffer (PBS + 2% FCS + 0.1% NaN 3) for 30 min at 4°C. 
The cells were centrifuged at 1600 x g for 10 min, washed 
3. Results 
3.1. Dose-dependent effects of PMA on the surface expres- 
sion and shedding of ICAM-1 
The effects of PMA on the expression and shedding of 
ICAM-1 on the surface of erythroleukemic cells K 562 and 
s. Fritz et aL / Biochimica et Biophysica Acta 1312 (1996) 255-261 257 
myelomonocytic cells U 937 is shown in Fig. 1. ICAM-1 
was determined by flow cytometry and found to be ex- 
pressed on all cells of both cell lines. Depending on the 
concentration of PMA, different effects on K 562 cells 
were found (Fig. 1A). At 1 nM PMA, the expression of 
ICAM-1 was increased about 4-fold within 24 h, whereas a
short-term treatment for 30 min with 100 nM PMA led to 
a significant cleavage of ICAM-1 from the surface of the 
cells. After an incubation with 100 nM PMA for 24 h, only 
a moderate increase of the ICAM-1 expression on the 
surface was observed (not shown), probably as result of 
both processes - -  expression and shedding. In contrast o 
these results with K 562 cells, on U 937 cells only a slight 
stimulation of the surface expression by 1 nM PMA, but 
no shedding after the treatment with 100 nM PMA for 30 
min was found (Fig. 1B). 
To investigate whether [CAM-1 in the cell supernatants 
was a proteolytic fragment or the intact molecule, media 
were analysed by ultra-centrifugation a d Western blot- 
ting. Cell-conditioned media were spun for 2 h at 200 000 
X g. This treatment resulted in only slightly diminished 
concentrations of ICAM-1 (94.6 ___ 3,8% S.E.), indicating 
that the PMA-induced ICAM-1 activity in the supernatants 
was not due to shed membrane vesicles or cell debris. 
Western blots showed a MW for the cellular fraction of 
~ 95 kDa, whereas in the supernatants only a protein with 
a relative mol wt. of ~ 87 kDa could be detected (Fig. 2). 
Obviously the ICAM-I  immunoreactivity in the medium is 
a proteolytic fragment of the intact molecule. 
Since the shedding of surface proteins is discussed as 
one mechanism of down-regulation [14,15], the short-term 
effect of PMA was further studied. Cells of both cell lines 
were incubated at 37°C with different concentrations of 
PMA for 30 min (Fig. 3). The treatment with 1 nM PMA 
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Fig. 1. Effect of PMA on the surface xpression ofICAM-I. K 562 cells (A) and U 937 cells (B) were cultured for 24 h at 37°C without PMA (control) or 
with 1 nM PMA or without PMA followed with 100 nM PMA for additional 30 min. Cell surface xpression ofICAM-1 was measured by flow cytometry 
and is shown as logarithm of fluorescence intensity. Under all conditions, ICAM-1 was expressed on 100% of the cells. 
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Fig. 2. Shedding of ICAM-1 after PMA stimulation. K 562 cells were 
stimulated for 30 min by 100 nM PMA. Lysates (Lys.) and supematants 
(Sup.) were analyzed by SDS-polyacrylamide gel electrophoresis and 
subsequent Western blotting. 
did not lead to any detectable c leavage of ICAM-1 f rom 
the cell surface. The maximal  effect of  shedding was found 
on K 562 cells in the presence of  100 nM PMA.  H igher  
concentrat ions of  PMA (500 nM)  did not further increase 
the extend of  shedding. No shedding could be observed on 
U 937 cells, even after incubat ion with 500 nM PMA.  
3.2. Effect of TNF-a on the shedding of lCAM-1 
I f  K 562 cells were cultured in the presence of  60 U /ml  
TNF-c~ for 24 h, the expression of  ICAM-1 was about 
threefold h igher  than in unst imulated cells (Table 1). Addi-  
t ion of  100 nM PMA to these cells for 30 min  decreased 
the ICAM-1 on the surface to about 65%, the same extend 
as found with unst imulated cells. 
The format ion of  s lCAM-1 was measured in the super- 
TNF-a on the PMA-induced shedding of ICAM-1 on K 562 
TNF-c~ Surface ICAM-1 (% MFI) Decrease by PMA (%) 
- PMA 100 nM PMA 
- 100 64.8  _+ 8.4 35.2  5 :8 .4  
+ 336+28 216_+26 35.6_+7.8 
slCAM-1 (ng/106 cells) A slCAM-I (ng/106 cells) 
- 1.64:t:0.56 2.06-t-0.60 0.40_+0.12 
+ 5.99-t-0.26 8.97+0.91 2.98_+0.66 
K 562 cells were incubated with or without 60 U/ml TNF-et for 24 h 
before PMA was added for 30 min. Surface expression of ICAM-1 was 
measured by cytofluorimetry and is given as % of mean fluorescence 
intensity found without PMA (% MFI+S.D. for n = 10). slCAM-1 levels 
were measured in the supernatants of the cultured cells by ELISA 
(means+S.D. for n = 8 (-TNF-c~), and n = 6 (+TNF-a)). The differ- 
ences between the values of slCAM-I with and without PMA (A 
slCAM-1) were significant (P < 0.05). 
natants of the cultured cells. The initial values were ob- 
ta ined after 24 h of  culture. TNF-et increased this value 
fourfold in paral lel to the increased express ion of  ICAM-1 
on the surface (Table 1). This indicates a st imulated shed- 
ding in the presence of  TNF-e~. Moreover ,  PMA caused an 
addit ional  c leavage of  ICAM-1 which is ref lected by a 
further increase of  s lCAM-1 (A s lCAM-1)  in the super- 
natants of  st imulated as well  as unst imulated cells. On 
TNF-(x st imulated U 937 cells, only the surface express ion 
of ICAM-  1 was increased, but again no release of  s lCAM-  1 
could be observed (data not shown).  
120~L - .. 
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Fig. 3. Dose-dependence of the short-term effect of PMA on the shedding of ICAM-1. K 562 (11) and U 937 cells ( • ) were incubated with various PMA 
concentrations for 30 min. Surface expression of ICAM-1 was measured by flow cytometry. Data are given in % of mean fluorescence intensity (MFI) 
found without PMA as mean + S.D. for n = 3. 
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Fig. 4, Time-course of PMA-induced shedding of ICAM-1 from K 562 cells. Unstimulated (• )  and stimulated cells (60 U /ml  TNF-c~ for 24 h, i )  were 
incubated with 100 nM PMA for the indicated times. The mean fluorescence intensity (MFI) is given as % of control + S.D. for n = 3. 
3.3. Time-course of PMA-induced shedding of ICAM-1 
Fig. 4 shows that the major decrease of surface ICAM-1 
on K 562 cells occurred within the first five min after the 
addition of PMA and that after 20 min a constant value of 
about 65% of the initial value was reached. The shedding 
of ICAM-1 from TNF-et stimulated cells had the same 
time-course as also shown in Fig. 4. The corresponding 
values of slCAM-1 determined in the supernatants of the 
cultured cells are presented in Fig. 5. In accordance to the 
observed ecrease of surface ICAM-1, the major increase 
was found after 5 min of incubation with PMA. 
Since the PMA-induced shedding of ICAM- 1 was found 
to be incomplete in cell populations, we used the fluores- 
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Fig. 5. Release of sICAM-1 by PMA. sICAM-1 was determined in the 
supernatants from unstimulated (D)  and TNF-a-stimulated (• )  cells of 
the experiments in Fig. 3. 
cence microscope to investigate this process on single 
cells. TNF-oL-stimulated K 562 cells were marked with a 
monoclonal anti-ICAM-1 antibody and a fluorescence- 
labelled polyclonal goat-anti-mouse antibody and then per- 
fused with 100 nM PMA at 37°C. The fluorescence inten- 
sity was found to decrease on all cells due to the PMA 
induced shedding (Fig. 6). The greatest changes occurred 
within the first five min and reached a maximum of 33% 
after 20 min in agreement with the cytofluorimetric mea- 
surements. 
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Fig. 6. Shedding of ICAM-I by PMA on TNF-oL-stimulated single cells. 
K 562 cells were cultured with 60 U /ml  TNF-et for 24 h and then 
marked with mAb against ICAM-1 and polyclonal DTAF-labelled goat- 
anti-mouse antibody. The curves show the changes in the fluorescence 
intensity of 8 single cells during perifusion with 100 nM PMA. 
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4. Discussion 
The expression of adhesion molecules on the surface of 
immune cells plays an important role in the inflammatory 
response. The mechanisms of down-regulation of these 
molecules are still unclear. One possible explanation for 
this phenomenon is the shedding of such surface proteins 
by a proteolytic cleavage, which has been shown for 
various receptor molecules [ 14,15]. For ICAM- 1, shedding 
was observed in parallel to the stimulation of its expres- 
sion by cytokines on melanoma cells [13,16,17]. Our stud- 
ies show that shedding of ICAM-1 can be induced by 
PMA in addition to the spontaneous cleavage from TNF-e~ 
stimulated cells. 
The presented results support he hypothesis that shed- 
ding is the main process by which soluble ICAM-I is 
produced [13,14] since the decrease of surface ICAM-1 
correlated with the elevated levels of slCAM-I detected in 
the supernatants of the cultured cells. Furthermore Western 
analyses revealed that the activity of ICAM-1 in the 
supernatants was due to a soluble protein with a reduced 
molecular weight as compared with the membrane-bound 
ICAM- I. 
No evidence for internalisation of ICAM-1 was ob- 
tained by fluorescence microscopy. The immunofluo- 
rescence of ICAM-1 on the surface of the cells appeared 
ring-shaped and decreased uring the perfusion with PMA 
without concentrating within the cells. These findings are 
in agreement with data of von Asmuth et al. [20] who 
observed an internalisation of E-selectin but not of ICAM- 1 
on TNF-a-stimulated endothelial cells. 
The expression and shedding of ICAM-1 by PMA was 
found to depend on the concentration and on the time of 
incubation. Whereas in the presence of 1 nM PMA the 
expression of ICAM- 1 on the surface was stimulated within 
24 h, the shedding of ICAM-1 was a short-term process 
requiring a 100-fold higher concentration of PMA. Phor- 
bolester-stimulated surface expression of ICAM-1 by low 
concentrations of PMA has been shown on endothelial and 
other cells of the immune system [3,21,22]. PMA-mediated 
shedding has been described for L-selectin [23,24], CD14 
[25], CD16-II [26], CD43 [27], interleukin 6 receptor [28] 
or TNF-et receptor [29]. The proteolytic removal of these 
molecules is a similar rapid process as we have observed 
for ICAM-1, ranging from 15 min for L-selectin [23,24] to 
1 h for CD43 [27] or the interleukin 6 receptor [28]. In 
contrast o the complete release of these molecules, we 
found only a partial shedding of ICAM-1. Whether this is 
caused by isoforms of ICAM-1 differing in the glycolysa- 
tion [5] or by other mechanisms has to be shown by further 
studies. 
Increased levels of slCAM-1 induced by PMA has only 
been described for JY cells and human renal carcinoma 
cell line CaKi-1 [9,18]. This was found to be in parallel to 
a stimulated expression on the cell surface. A similar 
parallel increase in the surface expression of ICAM-1 and 
in the formation of slCAM-1 was observed with endothe- 
lial [12] and melanoma cells [13,16,17] after the stimula- 
tion by cytokines. Hitherto it is not clear whether this 
increased shedding of ICAM-1 results from the increased 
surface expression by spontaneous hedding [14] or is 
produced by specific mechanisms. Our results show that 
shedding of ICAM-1 on K 562 cells can be induced by 
PMA additionally to the TNF-ot stimulated shedding. The 
PMA induced shedding of surface molecules has been 
discussed to be produced by a so far unknown protease at 
the cell surface which might be activated by protein kinase 
C [23-29]. The other possibility that protein kinase C 
activates the substrate by phosphorylation of ICAM-1 is 
not likely since motives for protein phosphorylation were 
not found in the cytosolic domain of ICAM-1 [30]. 
The PMA-induced shedding of ICAM- 1 seems to be not 
a common process for all cells. No ICAM-1 could be shed 
from U 937 cells in agreement with results of Rothlein et 
al. [9J. 
Summarizing the data, PMA induces a rapid shedding 
of ICAM-1 from K 562 cells which is different from the 
known stimulation of the surface expression of ICAM-1. 
This induced shedding proceeds similar to that of other 
cell surface molecules and may be produced by a common 
mechanism. 
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